by Stem Cell Network | Dec 29, 2010
Earlier this month, the Honourable Tony Clement, Minister of Industry, announced the establishment of the Centre for the Commercialization of Regenerative Medicine (CCRM) with a $15 million initial investment. The CCRM will be based in Toronto and is one of five new...
by Paul Krzyzanowski | Dec 20, 2010
Basic scientific research is a fundamental driver of improved quality of life that our society enjoys. However, it’s tacitly acknowledged that the benefits of research sometimes don’t materialize until some time has passed, with the finish line sometimes...
by Paul Krzyzanowski | Dec 14, 2010
One of the biggest choices graduate students and post-doctoral fellow face is whether to stay in academia or go into the business world. But what if the two weren’t really that different? Traditional advice about running a successful academic research group...
by Paul Krzyzanowski | Nov 17, 2010
In a previous post, Chris Kamel recently reviewed the Nature article about direct creation of blood progenitors from skin fibroblasts as discovered by Mick Bhatia’s research group. The fascinating thing about this article is the potential for enabling autologous...
by David Kent | Nov 10, 2010
One of the most memorable moments of my PhD training was at a 2006 Keystone conference where Shinya Yamanaka presented a little something called Pluripotency and Nuclear Reprogramming. He carefully presented the transcription factor screen that would culminate in the...
by David Kent | Sep 30, 2010
Last week, a major kerfuffle erupted in the UK stem cell community as leading scientists and pro stem cell organizations argued that Britain’s range of economic austerity measures would jeopardize their ability to be a major player in translational research. Articles...
Comments